Clinical Trials Logo

Genotyping Techniques clinical trials

View clinical trials related to Genotyping Techniques.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04473586 Completed - Clinical trials for Genotyping Techniques

Spartan Cube CYP2C19 Method Comparison Study

Start date: February 5, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to demonstrate concordance (percent agreement) between results produced by the Spartan CYP2C19 system and bi-directional sequencing. In addition, this study will evaluate the concordance of buccal samples stored prior to running on the Spartan Cube CYP2C19 system and bi-directional sequencing.

NCT ID: NCT04473573 Completed - Clinical trials for Genotyping Techniques

Spartan Cube CYP2C19 Inter Laboratory Reproducibilty Study

Start date: October 31, 2019
Phase: N/A
Study type: Interventional

The study verifies that the Spartan Cube CYP2C19 System generates reproducible results under multi-variant conditions including test site (three different test sites), operators (two operators per site), testing days (five non-consecutive days per site), and test kit lot (three different lots).

NCT ID: NCT01718535 Completed - Clinical trials for Genotyping Techniques

Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing

Start date: September 2012
Phase: N/A
Study type: Observational

The Spartan FRX CYP2C19 Test System (hereafter referred to as the 'FRX System') is a qualitative in vitro diagnostic test for the identification of a patient's CYP2C19 *2, *3 and *17 genotypes from genomic DNA obtained from buccal swab samples. This study is purposed to demonstrate the concordance (positive and negative percent agreement) by comparing the Spartan FRX system against bi-directional DNA sequencing. The study will also evaluate the concordance between three different sample transport embodiments provided to laboratories for use in transporting the reagent tubes with collected buccal sample swab to the laboratory.